Effect of blood transfusion on long-term survival after cardiac operation

被引:524
作者
Engoren, MC
Habib, RH
Zacharias, A
Schwann, TA
Riordan, CJ
Durham, SJ
机构
[1] St Vincent Mercy Med Ctr, Dept Anesthesiol, Toledo, OH 43608 USA
[2] St Vincent Mercy Med Ctr, Dept Cardiovasc Surg, Toledo, OH 43608 USA
[3] Med Coll Ohio, Toledo, OH 43699 USA
关键词
D O I
10.1016/S0003-4975(02)03766-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Blood transfusions have been linked to increased morbidity and mortality. Bleeding during and after cardiac operations and the hemodilution effects of cardiopulmonary bypass commonly result in blood transfusions. Because we could not find any studies evaluating the effects of transfusion on long-term survival after cardiac operation, we sought to determine these effects. Methods. We studied 1,915 patients who underwent first-time isolated coronary artery bypass operations between July 6, 1994 and December 31, 1997 at our institution. Patients with transfusions were compared with those who had not been transfused. Long-term survival data were obtained from the United States Social Security Death Index. Groups were compared by Cox proportional hazard models, Kaplan-Meier survival plots, and hazard functions. Results. Six hundred forty-nine of 1,915 study patients (34%) received a transfusion during their hospitalization. Transfused patients were older, smaller, and more likely to be female, and had more comorbidity. Transfused patients also had twice the 5-year mortality (15% vs 7%) of nontransfused patients. After correction for comorbidities and other factors, transfusion was still associated with a 70% increase in mortality (risk ratio = 1.7; 95% confidence interval = 1.4 to 2.0; p = 0.001). By multivariate analysis, transfusion, peripheral vascular disease, chronic obstructive pulmonary disease, New York Heart Association functional class IV, and age were significant predictors of long-term mortality. Conclusions. We found that blood transfusions during or after coronary artery bypass operations were associated with increased long-term mortality.
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 40 条
[1]  
*AM HEART ASS, 1999, 2000 HEART STROK STA, P26
[2]   Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma [J].
Asahara, T ;
Katayama, K ;
Itamoto, T ;
Yano, M ;
Hino, H ;
Okamoto, Y ;
Nakahara, H ;
Dohi, K ;
Moriwaki, K ;
Yuge, O .
WORLD JOURNAL OF SURGERY, 1999, 23 (07) :676-680
[3]  
BARTON JC, 1981, SEMIN HEMATOL, V18, P95
[4]  
Birkmeyer JD, 1996, ARCH SURG-CHICAGO, V131, P316
[5]   Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome [J].
Bracey, AW ;
Radovancevic, R ;
Riggs, SA ;
Houston, S ;
Cozart, H ;
Vaughn, WK ;
Radovancevic, B ;
McAllister, HA ;
Cooley, DA .
TRANSFUSION, 1999, 39 (10) :1070-1077
[6]   Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry [J].
Brooks, MM ;
Jones, RH ;
Bach, RG ;
Chaitman, BR ;
Kern, MJ ;
Orszulak, TA ;
Follmann, D ;
Sopko, G ;
Blackstone, EH ;
Califf, RM .
CIRCULATION, 2000, 101 (23) :2682-2689
[7]  
BURROWS L, 1982, LANCET, V2, P662
[8]   Size makes a difference: use of a low-prime cardiopulmonary bypass circuit and autologous priming in small adults [J].
Cormack, JE ;
Forest, RJ ;
Groom, RC ;
Morton, J .
PERFUSION-UK, 2000, 15 (02) :129-135
[9]   EFFECT OF TIMING OF ADMINISTRATION AND QUANTITY OF BLOOD-TRANSFUSION ON CADAVER RENAL-TRANSPLANT SURVIVAL [J].
CORRY, RJ ;
WEST, JC ;
HUNSICKER, LG ;
SCHANBACHER, BA ;
LACHENBRUCH, PA .
TRANSPLANTATION, 1980, 30 (06) :425-428
[10]   Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality [J].
Dávila-Román, VG ;
Murphy, SF ;
Nickerson, NJ ;
Kouchoukos, NT ;
Schechtman, KB ;
Barzilai, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (05) :1308-1316